# Opna Immuno-Oncology SA — Form D

Opna Immuno-Oncology SA of ST SULPICE, V8, a company, filed a Form D exempt-offering notice with the SEC on 2021-02-09. Industry: Biotechnology.

## Offering

- Filed: 2021-02-09
- Form: D
- Accession: 0001844923-21-000001
- Industry: Biotechnology
- Exemptions: 06b
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-388869

## Issuer

- Name: Opna Immuno-Oncology SA
- CIK: 0001844923
- Entity type: Corporation
- Jurisdiction: SWITZERLAND
- Incorporated: 2020
- Address: CHEMIN DES CHARMILLES 34, ST SULPICE, V8, 1025
- Phone: 41798479785

## Officers, directors & promoters (4)

| Name | Role | Location |
| --- | --- | --- |
| Gideon W Bollag | Director | Orinda, CA |
| Douglas Hanahan | Director | St Sulpice, V8 |
| Brian W Pusch | Director | New York, NY |
| Joseph W Schlessinger | Director | Woodbridge, CT |

## More

- [CIK 1844923 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1844923&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001844923-21-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.